Cancer Institute A national cancer institute
designated cancer center

Quynh-Thu Le

Publication Details

  • Phase I study of tirapazamine plus cisplatin/etoposide and concurrent thoracic radiotherapy in limited-stage small cell lung cancer (S0004): a Southwest Oncology Group study.

    Le QT, McCoy J, Williamson S, Ryu J, Gaspar LE, Edelman MJ, Dakhil SR, Sides SD, Crowley JJ, Gandara DR. Clin Cancer Res. 2004; 10 (16): 5418-24

    To determine the feasibility and a recommended phase II dose of tirapazamine when combined with chemoradiotherapy in limited-stage small cell lung cancer (LSCLC).

    PubMedID: 15328179

Stanford Medicine Resources:

Footer Links: